Beijing Double-Crane Pharmaceutical is engaged in the process and manufacture of raw material medicine, injection, tablet, capsule, granule, and pharmaceutical machinery equipment; the sale of self-developed products, mechanical and electrical equipment; and the provision of development and transfer of technology and related services. Through its subsidiaries, Co. is also engaged in the manufacture and sale of building decoration materials and cleaning products; the import and export of pharmaceutical products and machinery equipment; investment management; the manufacture and sale of beverage and health food; the installation of electro-mechanical equipment; and the maintenance of pipeline.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.